Recreational Ketamine Use among Individuals with Opioid Use Disorder: Demographics, Motivations, and Polysubstance Use.
Saved in:
| Title: | Recreational Ketamine Use among Individuals with Opioid Use Disorder: Demographics, Motivations, and Polysubstance Use. |
|---|---|
| Authors: | Chandler, Corinne L. (AUTHOR), Buttram, Mance E. (AUTHOR), Ellis, Matthew S. (AUTHOR) |
| Source: | Substance Use & Misuse. 2025, Vol. 60 Issue 9, p1375-1381. 7p. |
| Subjects: | Substance abuse, Cross-sectional method, Cocaine, Ketamine, Risk-taking behavior, Research funding, Psychological distress, Sex distribution, Help-seeking behavior, Descriptive statistics, Self medication, Population geography, Hallucinogenic drugs, Motivation (Psychology), Narcotics, Drug abuse, Cannabis (Genus), Alcohols (Chemical class), Drug abusers, Drugs of abuse |
| Geographic Terms: | United States |
| Abstract: | Background: Data show that recreational ketamine use appears to be increasing. This study aimed to understand how ketamine fits into broader polysubstance use in individuals with opioid use disorder (OUD). Methods: Survey data were collected from a sample of treatment-seeking individuals with OUD in March 2022. Results: Of 301 respondents, 28.6% reported lifetime ketamine use. Ketamine use was more frequently reported among males (61.9% vs. 37%; p < 0.001) and less frequently reported among individuals in rural locations (33.6% vs 15.7%; p < 0.002). Most respondents (70.9%) used ketamine to achieve a desired psychoactive effect, and 46.4% used to self-treat a physical or mental health problem, including mental distress symptoms and mitigating opioid withdrawal symptoms or cravings. Polysubstance use involving ketamine was prevalent (70.7%) and included marijuana (64.9%), alcohol (61.4%), cocaine (36.8%), MDMA (36.8%), hallucinogens (31.6%), prescription opioids (29.8%), and illicit opioids (29.8%). Negative experiences while using ketamine were reported by 32.1% and included central nervous system complications and mental distress. Conclusions: Among this sample of individuals with OUD, motivations for ketamine use are varied and polysubstance use is common. Such behaviors, even when attempting to self-treat OUD or other health problems may place individuals at risk for psychiatric or physical health conditions, including overdose or death. [ABSTRACT FROM AUTHOR] |
| Copyright of Substance Use & Misuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Background: Data show that recreational ketamine use appears to be increasing. This study aimed to understand how ketamine fits into broader polysubstance use in individuals with opioid use disorder (OUD). Methods: Survey data were collected from a sample of treatment-seeking individuals with OUD in March 2022. Results: Of 301 respondents, 28.6% reported lifetime ketamine use. Ketamine use was more frequently reported among males (61.9% vs. 37%; p < 0.001) and less frequently reported among individuals in rural locations (33.6% vs 15.7%; p < 0.002). Most respondents (70.9%) used ketamine to achieve a desired psychoactive effect, and 46.4% used to self-treat a physical or mental health problem, including mental distress symptoms and mitigating opioid withdrawal symptoms or cravings. Polysubstance use involving ketamine was prevalent (70.7%) and included marijuana (64.9%), alcohol (61.4%), cocaine (36.8%), MDMA (36.8%), hallucinogens (31.6%), prescription opioids (29.8%), and illicit opioids (29.8%). Negative experiences while using ketamine were reported by 32.1% and included central nervous system complications and mental distress. Conclusions: Among this sample of individuals with OUD, motivations for ketamine use are varied and polysubstance use is common. Such behaviors, even when attempting to self-treat OUD or other health problems may place individuals at risk for psychiatric or physical health conditions, including overdose or death. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 10826084 |
| DOI: | 10.1080/10826084.2025.2497950 |
